BSE: EVEXIA · Trading - Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Evexia Lifecare Limited is an Indian company based in Vadodara that engages in the trading and manufacturing of chemical, pharmaceutical, and agricultural products. The company has diversified its operations into healthcare services, edible oils, plastic granules, and is currently expanding into the e-mobility and specialty chemicals sectors.
The company generates revenue through a diversified trading and manufacturing model, supplying chemical and pharmaceutical intermediates alongside agricultural produce and consumer goods. It leverages its manufacturing facilities in Gujarat to serve both domestic and international markets.
Management is actively pivoting the company towards high-growth sectors such as specialty chemicals and e-mobility to enhance long-term value. The strategy focuses on portfolio diversification to reduce reliance on traditional trading segments.
Future growth is expected to be driven by the expansion into the e-mobility sector and the development of specialty chemical production capabilities. The company continues to invest in healthcare and laboratory testing services to broaden its revenue streams.
Unlock AI insights, financials, peers and live data on Evexia Lifecare and 5,000+ companies — free.
REVENUE
₹110 Cr
TTM · consolidated
NET PROFIT
₹2 Cr
TTM · consolidated
EPS
₹0.03
TTM · consolidated
RETURN ON EQUITY
0.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
0.3%
TTM · consolidated
P/E
53.3x
Q4 FY26 · consolidated
EV/EBITDA
33.8x
Q4 FY26 · consolidated
EBITDA MARGIN
3.0%
TTM · consolidated
NET PROFIT MARGIN
2.1%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0x
Q4 FY26 · consolidated
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Evexia LifecareEVEXIA | ₹276 Cr | 49.00 | 83.03 | 16.2% | 3.0% | 0.5% | 0.3% | -35.0% |
Uniphos Enterprises LimitedUNIENTER | ₹654 Cr | 31.68 | 29.74 | -71.3% | 67.2% | 0.8% | 0.8% | -38.2% |
Vinyl Chemicals (India) LimitedVINYLINDIA | ₹430 Cr | 23.01 | 16.92 | -3.2% | 4.2% | 14.5% | 19.4% | -13.7% |
A-1 LimitedA1L | ₹227 Cr | 7.16 | 21.39 | — | 3.7% | 11.5% | 18.5% | -99.5% |
As of Q4 FY26
Evexia Lifecare
BSE: EVEXIA · Trading - Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Evexia Lifecare Limited is an Indian company based in Vadodara that engages in the trading and manufacturing of chemical, pharmaceutical, and agricultural products. The company has diversified its operations into healthcare services, edible oils, plastic granules, and is currently expanding into the e-mobility and specialty chemicals sectors.
The company generates revenue through a diversified trading and manufacturing model, supplying chemical and pharmaceutical intermediates alongside agricultural produce and consumer goods. It leverages its manufacturing facilities in Gujarat to serve both domestic and international markets.
Management is actively pivoting the company towards high-growth sectors such as specialty chemicals and e-mobility to enhance long-term value. The strategy focuses on portfolio diversification to reduce reliance on traditional trading segments.
Future growth is expected to be driven by the expansion into the e-mobility sector and the development of specialty chemical production capabilities. The company continues to invest in healthcare and laboratory testing services to broaden its revenue streams.
Unlock AI insights, financials, peers and live data on Evexia Lifecare and 5,000+ companies — free.
REVENUE
₹110 Cr
TTM · consolidated
NET PROFIT
₹2 Cr
TTM · consolidated
EPS
₹0.03
TTM · consolidated
RETURN ON EQUITY
0.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
0.3%
TTM · consolidated
P/E
53.3x
Q4 FY26 · consolidated
EV/EBITDA
33.8x
Q4 FY26 · consolidated
EBITDA MARGIN
3.0%
TTM · consolidated
NET PROFIT MARGIN
2.1%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0x
Q4 FY26 · consolidated
As of Q4 FY26